| Name |
Imatinib, Methanesulfonate Salt
|
| Supplier |
Biorbyt
|
| Catalog |
orb61045
|
| Prices |
$272.00, $349.00, $366.00, $587.00, $663.00, $1,403.00
|
| Sizes |
500 mg, 1 g, 2 g, 5 g, 10 g, 25 g
|
| Cas Number |
[220127-57-1]
|
| Pubchem |
123596
|
| Chemical Name |
methanesulfonicacid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
|
| Formula |
C29H31N7O·CH4SO3
|
| Molecular Weight |
589.71 g/mol
|
| Purity |
>99% pure
|
| Description |
Imatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. Imatinib is currently being investigated in Phase III clinical trials in patients with Sarcoma.
|
| Supplier Page |
Shop
|
